National University, Rwanda   Report issue

Academic/Hospital Phase 3
Founded: Butare Rwanda (1963)

Organization Overview

First Clinical Trial
2011
NCT01424046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

ketamine (ketalar) (1 trial)

sodium chloride (1 trial)

Drugs in Other Trials (1)

insulin glargine (toujeo) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Pain, Postoperative (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3